Trial Profile
Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia; Renal failure
- Focus Therapeutic Use
- Acronyms LAVALIER
- 24 Feb 2021 Planned End Date changed from 31 Mar 2023 to 1 Sep 2023.
- 24 Feb 2021 Planned primary completion date changed from 1 Dec 2020 to 31 Mar 2023.
- 13 Jan 2021 Planned End Date changed from 1 Jun 2021 to 31 Mar 2023.